CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

RainTree Oncology In Deal With Flint’s Diplomat Specialty Pharmacy

View Comments
Diplomat Specialty Pharmacy's headquarters in Flint

Diplomat Specialty Pharmacy’s headquarters in Flint

mattroush Matt Roush
Matt Roush joined WWJ Newsradio 950 in September 2001 to spearhead the...
Read More

FLINT — San Diego, Calif.-based RainTree Oncology Services, a privately held provider of oral oncologic drug acquisition and management services, announced it has signed a service agreement with Flint-based Diplomat Specialty Pharmacy, the nation’s largest privately owned specialty pharmacy providing medication management and clinical services.

The agreement will enable RainTree to provide community oncology practices with better access to crucial oral oncology drugs, clinical programs and adherence-enhancing medication management programs.

“Diplomat is not only one of the nation’s largest dispensers of many oral oncolytics, such as Revlimid and Zytiga, but also brings impressive oncology-specific programs and data collection capabilities,” said Mike Martin, president and CEO of RainTree Oncology. “Their resources align with our physician centric, patient focused initiative to provide important data to community oncology practices. This will enable our customers to better support cancer care through analysis of cancer patient compliance, adherence and outcomes.”

Said Phil Hagerman, Diplomat’s president and CEO: “We are honored to be chosen by Raintree to be their specialty pharmacy partner. Working in close partnership with Raintree will facilitate enhanced services to Raintree physicians and improved outcomes for their patients. This model will secure access to complex oral oncolytics as well as implement drug-specific algorithms that will help mimic clinical trial efficacy.”

In the United States, community oncologists provide care for the majority of cancer patients. Increasingly, changes in healthcare economics are impacting how these practices operate, putting pressure on their ability to deliver essential services to their patients. Oral drug acquisition and management can be particularly problematic as the drugs are expensive and often are not fully reimbursed.

RainTree Oncology is building a network of community oncologists through which members will obtain pharmaceuticals at contracted prices — a savings that could be passed onto the patient or used to enhance patient services. In addition, RainTree Oncology will facilitate the implementation of in-practice pharmacies for practices that do not have one, providing an added convenience for patients and a key source of information for physicians.

Using technology tools provided by RainTree, practice pharmacists will be able to track both the prescribing and fulfillment of oral oncology medications in practices, as well as patient utilization of these drugs. Practice physicians and administrators can then use the information to elevate practice care and improve operations.

Diplomat focuses on complete medication management programs for patients with serious and chronic conditions. Diplomat creates unique programs with specialty distribution at retail focusing on improving adherence and the patient experience, as well as creating exclusive distribution models for its pharmaceutical partners.

More at www.raintreeoncology.com or www.diplomat.com.

View Comments
blog comments powered by Disqus